Cancel
Orca Bio
Orca Bio Employees
9 people indexed:
-
jh84@jy8fexg.g81 Sign up to see email
-
pje@646z8zj.s9e Sign up to see email
-
fw8pv@l507w2u.9j6 Sign up to see email
-
xs73@1dyu5td.5tw Sign up to see email
-
qwx5v0@5tp03h6.8v3 Sign up to see email
-
n49q@gxp31z4.ld6 Sign up to see email
-
d4600x@v39fhpx.x3k Sign up to see email
-
k4ju@yuvyl59.8ll Sign up to see email
-
nzn8y@7px8zj4.72d Sign up to see email
Orca Bio Company Information
Founded in 2016, Orca Bio is a biotechnology firm that develops innovative cell therapies intended to significantly enhance patient outcomes while minimizing the risks associated with traditional treatments. The company’s research originated from the laboratory of Dr. Irv Weissman, a leading stem cell researcher at Stanford University. Orca Bio presented positive results for their Orca-T and Orca-Q therapies at the 65th ASH Annual Meeting, highlighting their potential in transforming cell therapy. Their investigational therapies are designed to replace a patient’s diseased blood and immune system with a healthy one, thereby aiming to improve survival rates and quality of life. Orca Bio addresses critical complications such as Graft-versus-host disease (GvHD) by using a proprietary blend of natural immune cells and stem cells to engineer a ‘designer’ immune system. The company operates its own manufacturing facilities, enabling the reliable, large-scale production of high-precision cell therapies.
Report inaccurate information
Report inaccurate information
